| Code | Description | Claims | Beneficiaries | Total Paid |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
59,917 |
47,940 |
$3.85M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
59,199 |
47,476 |
$1.26M |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
59,538 |
47,280 |
$520K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,448 |
2,904 |
$12K |
| 80061 |
Lipid panel |
4,433 |
3,761 |
$11K |
| 82607 |
|
3,224 |
2,729 |
$6K |
| 82728 |
|
3,431 |
2,902 |
$6K |
| 84481 |
|
3,561 |
3,000 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,346 |
3,688 |
$5K |
| 84439 |
|
3,714 |
3,131 |
$4K |
| 82746 |
|
3,423 |
2,891 |
$4K |
| 80050 |
General health panel |
207 |
190 |
$3K |
| 80053 |
Comprehensive metabolic panel |
4,501 |
3,903 |
$3K |
| 83550 |
|
3,469 |
2,932 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,730 |
3,256 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
5,967 |
4,786 |
$2K |
| 83540 |
|
3,471 |
2,933 |
$2K |
| 83735 |
|
3,395 |
2,869 |
$2K |
| 84550 |
|
3,354 |
2,846 |
$2K |
| 84153 |
|
708 |
573 |
$1K |
| 86769 |
|
76 |
76 |
$1K |
| 84403 |
|
261 |
199 |
$996.26 |
| 81003 |
|
3,427 |
2,835 |
$973.39 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,536 |
3,903 |
$806.89 |
| 86803 |
|
153 |
126 |
$601.67 |
| 82043 |
|
522 |
436 |
$506.97 |
| 84480 |
|
2,721 |
2,382 |
$497.41 |
| 83970 |
|
156 |
126 |
$423.08 |
| 84436 |
|
2,855 |
2,489 |
$321.42 |
| 85610 |
|
797 |
549 |
$303.11 |
| 85651 |
|
320 |
260 |
$265.48 |
| 84100 |
|
190 |
153 |
$265.28 |
| 83690 |
|
130 |
107 |
$242.17 |
| 84402 |
|
41 |
33 |
$224.05 |
| 82150 |
|
119 |
96 |
$219.24 |
| 85044 |
|
201 |
163 |
$214.65 |
| 84270 |
|
41 |
33 |
$205.43 |
| 84479 |
|
2,704 |
2,367 |
$204.60 |
| 82550 |
|
115 |
93 |
$203.77 |
| 86140 |
|
167 |
138 |
$183.18 |
| 85730 |
|
493 |
382 |
$117.04 |
| 86592 |
|
106 |
85 |
$104.04 |
| 86618 |
|
38 |
31 |
$92.00 |
| 86706 |
|
41 |
32 |
$84.13 |
| 86038 |
|
240 |
214 |
$83.61 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
27 |
15 |
$82.11 |
| 86705 |
|
37 |
29 |
$81.72 |
| 87340 |
|
38 |
29 |
$77.56 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
133 |
94 |
$77.37 |
| 86696 |
|
79 |
68 |
$56.64 |
| 81015 |
|
1,543 |
1,340 |
$52.87 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
77 |
68 |
$50.87 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
76 |
67 |
$50.87 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
359 |
290 |
$42.46 |
| 87077 |
|
114 |
101 |
$37.56 |
| 86695 |
|
79 |
68 |
$36.46 |
| 86431 |
|
229 |
205 |
$36.12 |
| 86689 |
|
87 |
76 |
$32.07 |
| 86200 |
|
59 |
53 |
$20.72 |
| 84432 |
|
16 |
12 |
$13.00 |
| 81001 |
|
38 |
26 |
$1.00 |
| 86708 |
|
31 |
28 |
$0.00 |
| 86063 |
|
15 |
13 |
$0.00 |
| 87088 |
|
31 |
26 |
$0.00 |